Skip to main content
Premium Trial:

Request an Annual Quote

Michael Milburn, Lawrence Moreau, John Sharp, Eppendorf, Epicentre Biotechnologies

Premium

Pairings

Metabolon has appointed Michael Milburn as its chief scientific officer. Milburn most recently served at Sirtris Pharmaceuticals as senior vice president of research and corporate development. Prior to his position at Sirtris, Milburn was senior vice president of research at Plexxikon, and he held previous positions at Structural Genomix and GlaxoSmithKline. He received a PhD in structural chemistry at the University of California, Berkeley, and was a research fellow at Harvard Medical School.


Lawrence Moreau has been elected to Sequenom's board of directors and will be the chairman of the audit committee, the company said last week. Moreau, currently retired, founded financial advisory firm Moreau and Company and investment banking firm, Moreau Capital Corporation. He also was a board member and a licensed financial principal of an investment banking firm, and vice-president of Pacific Enterprises (now Sempra Energy). From 2003 to 2005, Moreau served on InterMix Media's board of directors. He's on the board of Chatsworth Products at this time.


John Sharp, Sequenom's current vice-president of finance, has been promoted to treasurer and principal financial officer. Sharp became vice-president in November 2004, when he left the director position at Diversa, which he held from August 2000. Sharp was a senior audit manager at PricewaterhouseCoopers from 1994 to 2000.

 

New Releases

Eppendorf said last month that it has released its DualChip GMO microarray for fast and safe analysis of genetically modified organisms in food. According to Eppendorf, the DualChip GMO kit enables the detection of GMOs in food in a standardized manner and can be used along with the company's Silverquant detection system to analyze GMO markers in parallel. Eppendorf said that it seeks to take advantage of new European Union guidelines that set a 0.9 percent limit for GMOs in saleable food. The company said that it has already initiated the technological validation by the EU.


Epicentre Biotechnologies this week launched its ArrayPure nano-scale RNA purification kit for purifying RNA from eukaryotic cells. Epicentre said that the kit contains only aqueous reagents and requires no toxic organic solvents.

Filed under